Latest profit margin for Imed Infinity Medical-Limited Partnership: -31.13% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), IMED.TA shows a profit margin of -31.13%. That compares with 281.9% in the prior-year period — down 111.0% year over year. That is below the sector sector average of 13.2%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, IMED.TA's profit margin is now -31.13% (was 281.9%) — a 111.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Imed Infinity Medical-Limited Partnership is outperforming or lagging.
The its sector sector average profit margin is about 13.2%. Imed Infinity Medical-Limited Partnership is at -31.13%, which is lower that average. That is roughly 335.8% below the sector mean. Use the comparison chart on this page to see how IMED.TA stacks up against individual peers as well.
That compares with 281.9% in the prior-year period — down 111.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Imed Infinity Medical-Limited Partnership with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Imed Infinity Medical-Limited Partnership's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -31.13%) with ownership activity and broader fundamentals.